Other Chronic pain
Conditions
Interventions
This is a double-blind, randomized controlled trial comprising two arms. The randomization sequence will be generated using the website http://www.randomizer.org, considering input from 2 groups and 1
10 = worst imaginable pain) by marking a perpendicular line on the scale. Subsequently, the distance marked in centimeters will be measured. Additionally, participants will be evaluated using pressure
E02.331.750
Sponsors
Universidade Federal de Juiz de Fora
Universidade Federal de Juiz de Fora
Eligibility
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Adults between 18 and 80 years old; with hearing acuity; no history of neuropsychiatric disorders or self-reported use of psychoactive substances; that are sufferers of chronic pain (for more than 3 months)
Exclusion criteria
Exclusion criteria: Individuals with epilepsy, taking anticonvulsant medication, and/or experiencing sleep deprivation; participants with metallic materials implanted in or near the head (e.g., cochlear implant, implanted electrodes/stimulators, aneurysm clips or coils, firearm projectile fragments, jewelry, and hair clips); participants with pacemakers or cardiac wires (Stents), or any other active device where interaction with an electric field may interfere with its functioning; participants with eczema on the head or trunk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that, through the non-invasive neuromodulation protocol using transcutaneous Direct Current Stimulation (tsDCS), there will be a decrease in perceived pain measured by the Visual Analog Scale (VAS) and an increase in pressure pain threshold. Additionally, there is an anticipated improvement in quality of life and a reduction in central sensitization when present | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are anticipated | — |
Countries
Brazil
Contacts
Public ContactAlexndre Barbosa
Universidade Federal de Juiz de Fora
Outcome results
None listed